Study of the association between estrogen receptor alpha gene expression in the levels of RNA and protein in primary breast tumors

سال انتشار: 1390
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 122

فایل این مقاله در 13 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_PRJMS-14-3_001

تاریخ نمایه سازی: 29 بهمن 1403

چکیده مقاله:

Objective: Estrogen receptor alpha protein status is determined by routine immunohistochemistry analysis in all malignant breast tumors. This assay has its limitations. RNA based techniques are potential complements for immunohistochemistry but it must be noticed that gene silencing may occur at different levels from RNA to protein. The aim of this study was the comparison of the results from these two assays and characterizing the tumors subgroup in which gene expression occurs at RNA level but the target protein is absent. Materials and Methods: ۹۲ primary breast tumors including their clinical and IHC results were collected before treatment. Estrogen receptor gene expression of tumors was studied by Reverse Transcription Polymerase Chain Reaction (RT PCR). In this assay, GAPDH was used as a reference gene. Results: ۳۶.۶ % of tumors with negative estrogen receptor protein showed gene expression at mRNA level. In this subgroup most of the patient were older than ۵۰ years and in stages ۳ or ۴ of breast cancer and had poor prognosis according to Nottingham prognostic index. Most cases of the perineural invasion have been seen in this subgroup. Conclusion: It seems that RT-PCR assay would enable us to recognize a subgroup of breast tumors with poor prognosis which expresses RNA but not protein.

نویسندگان

پانته آ ایزدی

Ph.D. Student, Department of Medical Genetics, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran

مهرداد نوروزی نیا

Assistant Professor, Department of Medical Genetics, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran

مرتضی کریمی پور

Assistant Professor, Department of Molecular Medicine, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran

محمدحمید کرباسیان

Breast Surgeon, Day Hospital, Tehran, Iran

محمدتقی اکبری

Assistant Professor, Department of Medical Genetics, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran

فروزنده فریدونی

Pathologist, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran

زهرا مستخدمین حسینی

Pathologist, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran

فاطمه کمالی

G.P. Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran

عیسی جهانزاد

Pathologist, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran